Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
Rhea-AI Summary
Standard BioTools (NASDAQ: LAB) announced it will publish third quarter 2025 financial results on Tuesday, November 4, 2025.
The company said the results will be released after U.S. market close.
Positive
- None.
Negative
- None.
News Market Reaction 6 Alerts
On the day this news was published, LAB gained 3.13%, reflecting a moderate positive market reaction. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $16M to the company's valuation, bringing the market cap to $520M at that time.
Data tracked by StockTitan Argus on the day of publication.
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish third quarter 2025 financial results on Tuesday, November 4, 2025, after U.S. market close.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq: LAB), has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop better medicines faster. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary SomaScan, mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.
Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms.
Patent and License Information: standardbio.com/legal/notices.
©2025 Standard BioTools Inc. All rights reserved.
Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.
Investor Contact:
ir@standardbio.com
FAQ
When will Standard BioTools (LAB) release third quarter 2025 results?
Will Standard BioTools (LAB) report Q3 2025 results during or after market hours?
What date should investors mark for Standard BioTools (LAB) Q3 2025 earnings?
Is the Standard BioTools (LAB) Q3 2025 release scheduled for a weekday or weekend?
Does the announcement state the exact time for Standard BioTools (LAB) Q3 2025 results?
What should shareholders expect on November 4, 2025 regarding Standard BioTools (LAB)?
